Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis
暂无分享,去创建一个
D. Hernandez | A. Singleton | Robert H. Brown | J. Hardy | D. Cleveland | Michael L. Garcia | Chris M. Ward | Crystal Evey | P. Sapp | Robert H. Brown | Peter Sapp | J. Hardy
[1] R. Liem,et al. Mutations in the neurofilament light gene linked to Charcot‐Marie‐Tooth disease cause defects in transport , 2005, Journal of neurochemistry.
[2] T. Gillingwater,et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.
[3] V. Meininger,et al. A Frameshift Deletion in Peripherin Gene Associated with Amyotrophic Lateral Sclerosis* , 2004, Journal of Biological Chemistry.
[4] R. Liem,et al. Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models. , 2004, Human molecular genetics.
[5] S. Chin,et al. A Pathogenic Peripherin Gene Mutation in a Patient with Amyotrophic Lateral Sclerosis , 2004, Brain pathology.
[6] John W Griffin,et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.
[7] J. Schulz,et al. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2 , 2004, Nature Genetics.
[8] S. Züchner,et al. The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy , 2004, Neuromuscular Disorders.
[9] G. Sobue,et al. Glu528del in NEFL is a polymorphic variant rather than a disease-causing mutation for Charcot-Marie-Tooth disease in Japan , 2004, Neurogenetics.
[10] E. Bertini,et al. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] Sameer B. Shah,et al. NF-M is an essential target for the myelin-directed “outside-in” signaling cascade that mediates radial axonal growth , 2003, The Journal of cell biology.
[12] J. Julien,et al. Peripherin is not a contributing factor to motor neuron disease in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase , 2003, Neurobiology of Disease.
[13] J. Julien,et al. A neurotoxic peripherin splice variant in a mouse model of ALS , 2003, The Journal of cell biology.
[14] J. Lupski,et al. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. , 2003, Brain : a journal of neurology.
[15] R. Liem,et al. Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation , 2002, Journal of Cell Science.
[16] G. Sobue,et al. Identification of novel sequence variants in the neurofilament‐light gene in a Japanese population: analysis of Charcot‐Marie‐Tooth disease patients and normal individuals , 2002, Journal of the peripheral nervous system : JPNS.
[17] C. Shaw,et al. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. , 2002, Human molecular genetics.
[18] J. Zidar,et al. A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family , 2002, Neurogenetics.
[19] N. Calcutt,et al. Gene replacement in mice reveals that the heavily phosphorylated tail of neurofilament heavy subunit does not affect axonal caliber or the transit of cargoes in slow axonal transport , 2002, The Journal of cell biology.
[20] Minh N. H. Nguyen,et al. Reduced number of unmyelinated sensory axons in peripherin null mice , 2002, Journal of neurochemistry.
[21] N. Hirokawa,et al. Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ , 2001, Cell.
[22] J. Julien,et al. Deregulation of Cdk5 in a Mouse Model of ALS Toxicity Alleviated by Perikaryal Neurofilament Inclusions , 2001, Neuron.
[23] C. van Broeckhoven,et al. Further evidence that neurofilament light chain gene mutations can cause Charcot‐Marie‐Tooth disease type 2E , 2001, Annals of neurology.
[24] N. Hirokawa,et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. , 2001, Cell.
[25] N. Hirokawa,et al. The C-terminal tail domain of neurofilament protein-H (NF-H) forms the crossbridges and regulates neurofilament bundle formation. , 2000, Journal of cell science.
[26] J. Julien,et al. Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] H. Zoghbi,et al. Neurobiology of disease , 2000, Current Opinion in Neurobiology.
[28] K. Fischbeck,et al. A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4 ) localizes to a 500-kb interval on chromosome 9q34 , 2000, Neurogenetics.
[29] J. Julien,et al. Extra Axonal Neurofilaments Do Not Exacerbate Disease Caused by Mutant Cu,Zn Superoxide Dismutase , 2000, Neurobiology of Disease.
[30] O. Evgrafov,et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. , 2000, American journal of human genetics.
[31] J. Kong,et al. Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis , 2000, Neuroscience Letters.
[32] J. Julien,et al. Late Onset Death of Motor Neurons in Mice Overexpressing Wild-Type Peripherin , 1999, The Journal of cell biology.
[33] A Al-Chalabi,et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. , 1999, Human molecular genetics.
[34] J. Slade,et al. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS) , 1998, Neuroreport.
[35] Q. Zhu,et al. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[36] Q. Zhu,et al. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] P. Wong,et al. Pathogenesis of two axonopathies does not require axonal neurofilaments , 1998, Nature.
[38] J. Julien,et al. Delayed Maturation of Regenerating Myelinated Axons in Mice Lacking Neurofilaments , 1997, Experimental Neurology.
[39] D. Nickerson,et al. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. , 1997, Nucleic acids research.
[40] L. Bruijn,et al. Sequence variants in human neurofilament proteins: Absence of linkage to familial amyotrophic lateral sclerosis , 1996, Annals of neurology.
[41] T. Crawford,et al. Subunit composition of neurofilaments specifies axonal diameter , 1996, The Journal of cell biology.
[42] J. Griffin,et al. Altered neurofilament phosphorylation and beta tubulin isotypes in Charcot‐Marie‐Tooth disease type 1 , 1994, Neurology.
[43] D. Cleveland,et al. A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease , 1994, Neuron.
[44] V. Meininger,et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. , 1994, Human molecular genetics.
[45] P. Wong,et al. Neurofilaments are obligate heteropolymers in vivo , 1993, The Journal of cell biology.
[46] R. Liem,et al. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments , 1993, The Journal of cell biology.
[47] J. Julien,et al. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis , 1993, Cell.
[48] L. Cork,et al. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease , 1993, Cell.
[49] O. Ohara,et al. Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene , 1993, The Journal of cell biology.
[50] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[51] A. Hirano. Cytopathology of amyotrophic lateral sclerosis. , 1991, Advances in neurology.
[52] A. Hirano,et al. Fine Structural Observations of Neurofilamentous Changes in Amyotrophic Lateral Sclerosis , 1984, Journal of neuropathology and experimental neurology.
[53] L. Kurland,et al. Fine Structural Study of Neurofibrillary Changes in a Family with Amyotrophic Lateral Sclerosis , 1984, Journal of neuropathology and experimental neurology.
[54] Hughes Jt,et al. Pathology of amyotrophic lateral sclerosis. , 1982 .
[55] S. Carpenter. Proximal axonal enlargement in motor neuron disease , 1968, Neurology.